Paper39639656
Paraneoplastic Syndromes of the Nervous System in Patients Suffering from SCLC. A Review of the Recent Literature.
Georgiannakis E and 2 others. Acta Med Acad, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Paraneoplastic Syndromes of the Nervous System in Patients Suffering from SCLC. A Review of the Recent Literature. Papers, record 39639656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39639656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Paraneoplastic Syndromes of the Nervous System in Patients Suffering from SCLC. A Review of the Recent Literature.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Small Cell Lung Carcinoma | Major topic |
| Paraneoplastic Syndromes, Nervous System | Major topic |
| Lung Neoplasms | Major topic |
| Humans |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33864941 | Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. | Ann Oncol | 2021 | https://conductscience.org/library/papers/33864941 | PubMed |
| 2 | 2830955 | Neurologic disorders in patients with small cell lung cancer. | Cancer | 1987 | https://conductscience.org/library/papers/2830955 | PubMed |
| 3 | 9256130 | Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. | J Clin Oncol | 1997 | https://conductscience.org/library/papers/9256130 | PubMed |
| 4 | 18339348 | Paraneoplastic syndromes of the CNS. | Lancet Neurol | 2008 | https://conductscience.org/library/papers/18339348 | PubMed |
| 5 | 34287773 | Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer. | Invest New Drugs | 2022 | https://conductscience.org/library/papers/34287773 | PubMed |
| 6 | 35991099 | Narrative Reviews: Flexible, Rigorous, and Practical. | J Grad Med Educ | 2022 | https://conductscience.org/library/papers/35991099 | PubMed |
| 7 | 35117656 | Neurological paraneoplastic syndrome caused by small cell lung cancer: a case report. | Transl Cancer Res | 2020 | https://conductscience.org/library/papers/35117656 | PubMed |
| 8 | 20810794 | Paraneoplastic syndromes: an approach to diagnosis and treatment. | Mayo Clin Proc | 2010 | https://conductscience.org/library/papers/20810794 | PubMed |
| 9 | 9227955 | Paraneoplastic neuromuscular syndromes. | Neurol Clin | 1997 | https://conductscience.org/library/papers/9227955 | PubMed |
| 10 | 33209464 | Paraneoplastic syndromes in small cell lung cancer. | J Thorac Dis | 2020 | https://conductscience.org/library/papers/33209464 | PubMed |
| 11 | 14561798 | Paraneoplastic syndromes involving the nervous system. | N Engl J Med | 2003 | https://conductscience.org/library/papers/14561798 | PubMed |
| 12 | 31668313 | SCLC, Paraneoplastic Syndromes, and the Immune System. | J Thorac Oncol | 2019 | https://conductscience.org/library/papers/31668313 | PubMed |
| 13 | 33960258 | Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes. | Expert Rev Neurother | 2021 | https://conductscience.org/library/papers/33960258 | PubMed |
| 14 | 23937626 | Paraneoplastic neurological syndromes. | Clin Exp Immunol | 2014 | https://conductscience.org/library/papers/23937626 | PubMed |
| 15 | 30792503 | Radiotherapy toxicity. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/30792503 | PubMed |
| 16 | 14643918 | Complicated paraneoplastic neurological syndromes: a report of two patients with small cell or non-small cell lung cancer. | Clin Neurol Neurosurg | 2003 | https://conductscience.org/library/papers/14643918 | PubMed |
| 18 | 34242487 | Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers. | Thorac Cancer | 2021 | https://conductscience.org/library/papers/34242487 | PubMed |
| 19 | 34217018 | A paraneoplastic syndrome misdiagnosed as ALS: What are the red flags? A case report and review of the literature. | J Neuroimmunol | 2021 | https://conductscience.org/library/papers/34217018 | PubMed |
| 20 | 29411193 | [Paraneoplastic cerebellar degeneration (PCD) - an interdisciplinary challenge in neurology, oncology and palliative care]. | Wien Med Wochenschr | 2018 | https://conductscience.org/library/papers/29411193 | PubMed |
| 21 | 35173717 | Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China. | Front Immunol | 2022 | https://conductscience.org/library/papers/35173717 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40333678 | Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives. | Molecules | 2025 | https://conductscience.org/library/papers/40333678 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39639656
GET https://conductscience.org/api/papers/v1/39639656/references?page=2